IBDEI09C ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12391,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,12391,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,12391,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,12392,0)
 ;;=394.0^^61^671^13
 ;;^UTILITY(U,$J,358.3,12392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12392,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,12392,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,12392,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,12393,0)
 ;;=796.3^^61^671^12
 ;;^UTILITY(U,$J,358.3,12393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12393,1,3,0)
 ;;=3^796.3
 ;;^UTILITY(U,$J,358.3,12393,1,4,0)
 ;;=4^LOW BLOOD PRESSURE READING
 ;;^UTILITY(U,$J,358.3,12393,2)
 ;;=^273465
 ;;^UTILITY(U,$J,358.3,12394,0)
 ;;=796.2^^61^671^9
 ;;^UTILITY(U,$J,358.3,12394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12394,1,3,0)
 ;;=3^796.2
 ;;^UTILITY(U,$J,358.3,12394,1,4,0)
 ;;=4^ELEVATED B/P w/o HTN
 ;;^UTILITY(U,$J,358.3,12394,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,12395,0)
 ;;=285.9^^61^672^1
 ;;^UTILITY(U,$J,358.3,12395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12395,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,12395,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,12395,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,12396,0)
 ;;=266.2^^61^672^2
 ;;^UTILITY(U,$J,358.3,12396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12396,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,12396,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,12396,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,12397,0)
 ;;=272.0^^61^672^3
 ;;^UTILITY(U,$J,358.3,12397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12397,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,12397,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,12397,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,12398,0)
 ;;=250.00^^61^672^6
 ;;^UTILITY(U,$J,358.3,12398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12398,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,12398,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
 ;;^UTILITY(U,$J,358.3,12398,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,12399,0)
 ;;=250.02^^61^672^5
 ;;^UTILITY(U,$J,358.3,12399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12399,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,12399,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE II UNCONT
 ;;^UTILITY(U,$J,358.3,12399,2)
 ;;=^295704
 ;;^UTILITY(U,$J,358.3,12400,0)
 ;;=272.4^^61^672^9
 ;;^UTILITY(U,$J,358.3,12400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12400,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,12400,1,4,0)
 ;;=4^HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,12400,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,12401,0)
 ;;=244.9^^61^672^10
 ;;^UTILITY(U,$J,358.3,12401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12401,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,12401,1,4,0)
 ;;=4^HYPOTHYROIDISM
 ;;^UTILITY(U,$J,358.3,12401,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,12402,0)
 ;;=250.01^^61^672^4
 ;;^UTILITY(U,$J,358.3,12402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12402,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,12402,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE I
 ;;^UTILITY(U,$J,358.3,12402,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,12403,0)
 ;;=278.01^^61^672^11
 ;;^UTILITY(U,$J,358.3,12403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12403,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,12403,1,4,0)
 ;;=4^OBESITY, MORBID
 ;;^UTILITY(U,$J,358.3,12403,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,12404,0)
 ;;=286.59^^61^672^7
 ;;^UTILITY(U,$J,358.3,12404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12404,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,12404,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,12404,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,12405,0)
 ;;=268.9^^61^672^12
 ;;^UTILITY(U,$J,358.3,12405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12405,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,12405,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,12405,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,12406,0)
 ;;=790.29^^61^672^8
 ;;^UTILITY(U,$J,358.3,12406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12406,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,12406,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,12406,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,12407,0)
 ;;=389.9^^61^673^7
 ;;^UTILITY(U,$J,358.3,12407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12407,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,12407,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,12407,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,12408,0)
 ;;=380.4^^61^673^8
 ;;^UTILITY(U,$J,358.3,12408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12408,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,12408,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,12408,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,12409,0)
 ;;=382.9^^61^673^9
 ;;^UTILITY(U,$J,358.3,12409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12409,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,12409,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,12409,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,12410,0)
 ;;=365.11^^61^673^5
 ;;^UTILITY(U,$J,358.3,12410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12410,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,12410,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,12410,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,12411,0)
 ;;=372.72^^61^673^11
 ;;^UTILITY(U,$J,358.3,12411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12411,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,12411,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,12411,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,12412,0)
 ;;=365.70^^61^673^1
 ;;^UTILITY(U,$J,358.3,12412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12412,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,12412,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,12412,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,12413,0)
 ;;=365.71^^61^673^3
 ;;^UTILITY(U,$J,358.3,12413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12413,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,12413,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,12413,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,12414,0)
 ;;=365.72^^61^673^4
 ;;^UTILITY(U,$J,358.3,12414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12414,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,12414,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,12414,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,12415,0)
 ;;=365.73^^61^673^6
 ;;^UTILITY(U,$J,358.3,12415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12415,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,12415,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,12415,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,12416,0)
 ;;=365.74^^61^673^2
 ;;^UTILITY(U,$J,358.3,12416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12416,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,12416,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,12416,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,12417,0)
 ;;=461.9^^61^673^10
 ;;^UTILITY(U,$J,358.3,12417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12417,1,3,0)
 ;;=3^461.9
 ;;^UTILITY(U,$J,358.3,12417,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,12417,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,12418,0)
 ;;=571.5^^61^674^1
 ;;^UTILITY(U,$J,358.3,12418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12418,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,12418,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,12418,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,12419,0)
 ;;=530.81^^61^674^2
 ;;^UTILITY(U,$J,358.3,12419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12419,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,12419,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,12419,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,12420,0)
 ;;=558.9^^61^674^4
 ;;^UTILITY(U,$J,358.3,12420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12420,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,12420,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
 ;;^UTILITY(U,$J,358.3,12420,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,12421,0)
 ;;=564.1^^61^674^8
 ;;^UTILITY(U,$J,358.3,12421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12421,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,12421,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,12421,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,12422,0)
 ;;=211.3^^61^674^9
 ;;^UTILITY(U,$J,358.3,12422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12422,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,12422,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,12422,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,12423,0)
 ;;=533.90^^61^674^10
 ;;^UTILITY(U,$J,358.3,12423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12423,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,12423,1,4,0)
 ;;=4^ULCER, PEPTIC
 ;;^UTILITY(U,$J,358.3,12423,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,12424,0)
 ;;=535.00^^61^674^3
 ;;^UTILITY(U,$J,358.3,12424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12424,1,3,0)
 ;;=3^535.00
 ;;^UTILITY(U,$J,358.3,12424,1,4,0)
 ;;=4^GASTRITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,12424,2)
 ;;=^270169
 ;;^UTILITY(U,$J,358.3,12425,0)
 ;;=070.54^^61^674^6
 ;;^UTILITY(U,$J,358.3,12425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12425,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,12425,1,4,0)
 ;;=4^HEPATITIS C,CHRONIC,W/O COMA
 ;;^UTILITY(U,$J,358.3,12425,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,12426,0)
 ;;=553.9^^61^674^7
 ;;^UTILITY(U,$J,358.3,12426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12426,1,3,0)
 ;;=3^553.9
 ;;^UTILITY(U,$J,358.3,12426,1,4,0)
 ;;=4^HERNIA
 ;;^UTILITY(U,$J,358.3,12426,2)
 ;;=^56659
 ;;^UTILITY(U,$J,358.3,12427,0)
 ;;=455.6^^61^674^5
 ;;^UTILITY(U,$J,358.3,12427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12427,1,3,0)
 ;;=3^455.6
 ;;^UTILITY(U,$J,358.3,12427,1,4,0)
 ;;=4^HEMORRHOIDS NOS
 ;;^UTILITY(U,$J,358.3,12427,2)
 ;;=^123922
 ;;^UTILITY(U,$J,358.3,12428,0)
 ;;=607.84^^61^675^7
 ;;^UTILITY(U,$J,358.3,12428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12428,1,3,0)
 ;;=3^607.84
 ;;^UTILITY(U,$J,358.3,12428,1,4,0)
 ;;=4^IMPOTENCE, ORGANIC ORIGN
 ;;^UTILITY(U,$J,358.3,12428,2)
 ;;=^270441
